Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Investigative Dermatology

• Publication date

  2016-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jid.2016.01.039PMID 26945879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retinoic acid receptors: from molecular mechanisms to cancer therapy.

  2015cited by this paper
• Vitamin A, Cancer Treatment and Prevention: The New Role of Cellular Retinol Binding Proteins

  2015cited by this paper
• EGF receptor trafficking: consequences for signaling and cancer

  2014cited by this paper
• CRBP-1 expression in ovarian cancer: a potential therapeutic target.

  2014cited by this paper
• Icotinib, a potent and specific EGFR tyrosine kinase inhibitor, inhibits growth of squamous cell carcinoma cell line A431 through negatively regulating AKT signaling.

  2013cited by this paper
• Non-melanoma skin cancer: carcinogenesis and chemoprevention

  2013cited by this paper
• Molecular Pathways Molecular Pathways : Current Role and Future Directions of the Retinoic Acid Pathway in Cancer Prevention and Treatment

  2013cited by this paper
• Platelet‐Rich Plasma Greatly Potentiates Insulin‐Induced Adipogenic Differentiation of Human Adipose‐Derived Stem Cells Through a Serine/Threonine Kinase Akt‐Dependent Mechanism and Promotes Clinical Fat Graft Maintenance

  2012cited by this paper
• Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas.

  2011cited by this paper
• Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma.

  2011cited by this paper
• Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas

  2010cited by this paper
• Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt Signaling Suppresses Cell Proliferation and Survival through Regulation of Stat3 Activation in Human Cutaneous Squamous Cell Carcinoma

  2010cited by this paper
• Incidence estimate of nonmelanoma skin cancer in the United States, 2006.

  2010cited by this paper
• A placental growth factor variant unable to recognize vascular endothelial growth factor (VEGF) receptor-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization.

  2010cited by this paper
• Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1

  2010cited by this paper
• Propionyl-l-Carnitine Improves Postischemic Blood Flow Recovery and Arteriogenetic Revascularization and Reduces Endothelial NADPH-Oxidase 4–Mediated Superoxide Production

  2010cited by this paper
• Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications

  2009cited by this paper
• Transport and metabolism of vitamin A.

  2009cited by this paper
• Cellular Retinoic Acid‐binding Protein II: A Coactivator of the Transactivation by the Retinoic Acid Receptor Complex RAR.RXR

  2009cited by this paper
• Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.

  2009cited by this paper
• Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion

  2009cited by this paper
• All-trans retinoic acid-induced hyaluronan production and hyperplasia are partly mediated by EGFR signaling in epidermal keratinocytes.

  2008cited by this paper
• Management of nonmelanoma skin cancer in 2007

  2007cited by this paper
• Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors.

  2007cited by this paper
• The Ki67+ proliferation index correlates with increased cellular retinol‐binding protein‐1 and the coordinated loss of plakophilin‐1 and desmoplakin during progression of cervical squamous lesions

  2007cited by this paper
• Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes.

  2007cited by this paper
• Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications

  2006cited by this paper
• Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity.

  2005cited by this paper
• Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas.

  2005cited by this paper
• ERBB receptors and cancer: the complexity of targeted inhibitors

  2005cited by this paper
• Cellular retinol‐binding protein‐1 expression in endometrial stromal cells: physiopathological and diagnostic implications

  2004cited by this paper
• Role of ageing and coronary atherosclerosis in the development of cardiac fibrosis in the rabbit.

  2004cited by this paper
• Retinoic acid mediates degradation of IRS-1 by the ubiquitin–proteasome pathway, via a PKC-dependant mechanism

  2004cited by this paper
• Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases

  2004cited by this paper
• Retinoic Acid Is a High Affinity Selective Ligand for the Peroxisome Proliferator-activated Receptor β/δ*

  2003cited by this paper
• Retinoids in cancer therapy and chemoprevention: promise meets resistance

  2003cited by this paper
• Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin

  2003cited by this paper
• Direct Channeling of Retinoic Acid between Cellular Retinoic Acid-Binding Protein II and Retinoic Acid Receptor Sensitizes Mammary Carcinoma Cells to Retinoic Acid-Induced Growth Arrest

  2002cited by this paper
• The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

  2002cited by this paper
• Topical retinoic acid alters the expression of cellular retinoic acid‐binding protein‐I and cellular retinoic acid‐binding protein‐II in non‐lesional but not lesional psoriatic skin

  2002cited by this paper
• Retinoids Suppress Epidermal Growth Factor-associated Cell Proliferation by Inhibiting Epidermal Growth Factor Receptor-dependent ERK1/2 Activation*

  2002cited by this paper
• Physiological and retinoid‐induced proliferations of epidermis basal keratinocytes are differently controlled

  2002cited by this paper
• High levels of cellular retinol binding protein-1 expression in leiomyosarcoma: possible implications for diagnostic evaluation

  2002cited by this paper
• Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.

  2002cited by this paper
• The novel co-activator CRABPII binds to RARalpha and RXRalpha via two nuclear receptor interacting domains and does not require the AF-2 'core'.

  2001cited by this paper
• The novel co‐activator CRABPII binds to RARα and RXRα via two nuclear receptor interacting domains and does not require the AF‐2 ‘core’

  2001cited by this paper
• Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis.

  2001cited by this paper
• Cellular retinoic acid-binding protein II: a coactivator of the transactivation by the retinoic acid receptor complex RAR.RXR.

  2000cited by this paper
• Retinoid-binding proteins: mediators of retinoid action.

  2000cited by this paper
• Retinoic Acid Promotes Ubiquitination and Proteolysis of Cyclin D1 during Induced Tumor Cell Differentiation*

  1999cited by this paper
• Retinoid metabolism in the skin.

  1998cited by this paper
• Increased concentrations of 3,4-didehydroretinol and retinoic acid-binding protein (CRABPII) in human squamous cell carcinoma and keratoacanthoma but not in basal cell carcinoma of the skin.

  1996cited by this paper
• Treatment of inflammatory linear verrucous epidermal naevus with calcipotriol

  1995cited by this paper
• Punctate porokeratotic keratoderma—its occurrence with internal neoplasia

  1994cited by this paper
• Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro.

  1994cited by this paper
• Epidermal differentiation enhances CRABP II expression in human skin.

  1994cited by this paper
• Transcriptional control of epidermal growth factor receptor by retinoic acid.

  1992cited by this paper
• Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7,12-dimethylbenz(a)anthracene application and ultraviolet irradiation.

  1991cited by this paper
• Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid-induced expression of CRABP-II but not CRABP-I in adult human skin in vivo and in skin fibroblasts in vitro.

  1991cited by this paper
• Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis.

  1988cited by this paper

• CRABP2 promotes cell migration and invasion by activating PI3K/AKT and MAPK signaling pathways via up-regulating LAMB3 in prostate cancer.

  2024cites this paper
• Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations

  2023influential citation
• The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review

  2022cites this paper
• Retinoids in Cutaneous Squamous Cell Carcinoma

  2021influential citation
• Cellular Retinoic-Acid Binding Protein 2 in solid tumor.

  2020cites this paper
• Topical Proretinal Nanoparticles: Biological Activities, Epidermal Proliferation and Differentiation, Follicular Penetration, and Skin Tolerability.

  2020cites this paper
• Cellular retinoic acid binding protein-II expression and its potential role in skin aging

  2019cites this paper
• Investigational drugs currently in phase II clinical trials for actinic keratosis

  2019cites this paper
• Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas

  2018cites this paper
• Expression and potential role of cellular retinol binding protein I in psoriasis

  2018cites this paper
• Activation of the CRABPII/RAR pathway by curcumin induces retinoic acid mediated apoptosis in retinoic acid resistant breast cancer cells

  2017influential citation
• Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments

  2017cites this paper